Sign Out
Gabapentin is contra-indicated in patients who are hypersensitive to Gabapentin or the product's components.
NEUROSANTIN is contra-indicated in patients with acute pancreatitis.
NEUROSANTIN is not effective against primarily generalized seizures, such as absences.
No systematic studies in patients 65 years or older have been conducted with NEUROSANTIN. However, clinical investigations in this age group do not indicate an adverse event profile different from that observed in younger patients.
Epilepsy: There is not yet sufficient experience for add-on therapy in children below 3 years of age.
